Wealthspring Capital’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Wealthspring Capital’s Portfolio BLACU Stock Details BLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-22,550	Closed	-$239K	–	83
2023 Q3	$239K	Hold	22,550	–	–	0.41%	39
2023 Q2	$237K	Hold	22,550	–	–	0.33%	53
2023 Q1	$232K	Buy	+22,550	New	+$231K	0.38%	68

Other funds holding BLACU

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wealthspring Capital's BLACU Position: Q4 2023 in Review

Wealthspring Capital sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 22,550 shares — an estimated $239K sold.

Wealthspring Capital first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $239K in Q3 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

Wealthspring Capital reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
Wealthspring Capital sold 22,550 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $239K.
Wealthspring Capital first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
Wealthspring Capital's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $239K in Q3 2023.
2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on Wealthspring Capital's 13F filing for Q4 2023, filed 16 Jan 2024.